J Korean Med Assoc.  2007 Apr;50(4):337-342. 10.5124/jkma.2007.50.4.337.

HIV/AIDS Vaccine

Affiliations
  • 1Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Korea. seran@yumc.yonsei.ac.kr

Abstract

Recent researches have suggested approaches to HIV immunization that might result in at least a partially effective vaccine against infection with HIV-1. In particular, advances in our understanding of animal models, the vaccine-elicited celluar immunity and neutralizing antibody provide rational strategies for the development of this vaccine. Some advanced-phase clinical trials of HIV vaccine are ongoing. Although the creation of an effective HIV-1 vaccine remains an enormous challenge, the continuing progress in these areas provides a reason to be optimistic about our ultimate ability to control the spread of AIDS.

Keyword

Human immunodeficiency virus; HIV; Acquired immunodeficiency syndrome; AIDS; Vaccine

MeSH Terms

Acquired Immunodeficiency Syndrome
Antibodies, Neutralizing
HIV
HIV-1
Immunization
Models, Animal
Antibodies, Neutralizing
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr